These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21358637)

  • 1. Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21.
    Wang Y; Fisher JC; Mathew R; Ou L; Otieno S; Sublet J; Xiao L; Chen J; Roussel MF; Kriwacki RW
    Nat Chem Biol; 2011 Apr; 7(4):214-21. PubMed ID: 21358637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.
    Kriwacki RW; Hengst L; Tennant L; Reed SI; Wright PE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11504-9. PubMed ID: 8876165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21: structure and functions associated with cyclin-CDK binding.
    Ball KL
    Prog Cell Cycle Res; 1997; 3():125-34. PubMed ID: 9552411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the LH subdomain in the function of the Cip/Kip cyclin-dependent kinase regulators.
    Otieno S; Grace CR; Kriwacki RW
    Biophys J; 2011 May; 100(10):2486-94. PubMed ID: 21575583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-binding motifs are essential for the function of p21CIP1.
    Chen J; Saha P; Kornbluth S; Dynlacht BD; Dutta A
    Mol Cell Biol; 1996 Sep; 16(9):4673-82. PubMed ID: 8756624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic protein flexibility in regulation of cell proliferation: advantages for signaling and opportunities for novel therapeutics.
    Follis AV; Galea CA; Kriwacki RW
    Adv Exp Med Biol; 2012; 725():27-49. PubMed ID: 22399317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New functional activities for the p21 family of CDK inhibitors.
    LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
    Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
    Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
    J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
    Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
    Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
    Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle regulation by the intrinsically disordered proteins p21 and p27.
    Yoon MK; Mitrea DM; Ou L; Kriwacki RW
    Biochem Soc Trans; 2012 Oct; 40(5):981-8. PubMed ID: 22988851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CDK inhibitors].
    Toyoshima H
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1562-6. PubMed ID: 9279082
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
    Parry D; Mahony D; Wills K; Lees E
    Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding.
    Lacy ER; Filippov I; Lewis WS; Otieno S; Xiao L; Weiss S; Hengst L; Kriwacki RW
    Nat Struct Mol Biol; 2004 Apr; 11(4):358-64. PubMed ID: 15024385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of p21(Waf1/Cip1/Sdi1) C-terminal domain bound to Cdk4.
    Sung YH; Shin J; Shin J; Lee W
    J Biomol Struct Dyn; 2001 Dec; 19(3):419-27. PubMed ID: 11790141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.